Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;10(16):860.
doi: 10.21037/atm-22-3384.

XGBoost algorithm and logistic regression to predict the postoperative 5-year outcome in patients with glioma

Affiliations

XGBoost algorithm and logistic regression to predict the postoperative 5-year outcome in patients with glioma

Zhiqiang Yan et al. Ann Transl Med. 2022 Aug.

Abstract

Background: Glioma is the most common primary intracranial tumor with poor prognosis. The prediction of glioma prognosis has not been well investigated. XGBoost algorithm has been widely used in and data analysis. The predictive value of XGBoost algorithm in glioma remains unclear. This current study used the XGBoost algorithm to construct a predictive model for postoperative outcomes of glioma patients.

Methods: Patients with glioma who underwent surgery from January 2006 to April 2017 were retrospectively included in this study. Clinical and follow-up data were collected. The XGBoost model and multivariate logistic regression analysis model were used to screen the factors related to postoperative outcomes, and the results of the two models were compared. The area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and Youden index were calculated to evaluate the predictive value of the XGBoost model.

Results: A total of 638 patients were included. In total, 336 (52.7%) cases died within 5 years after the operation. Multivariate logistic regression analysis showed that age, gender, World Health Organization (WHO) grade, extent of tumor resection, Karnofsy performance score (KPS), tumor diameter, and whether postoperative radiotherapy and chemotherapy were administered, were the most important risk factors for death within 5 years after surgery in glioma patients. The XGBoost model showed that the top 5 factors related to death of glioma patients within 5 years after surgery were WHO grade (30 points), extent of tumor resection (19 points), postoperative radiotherapy and chemotherapy (16 points), KPS (14 points), and age (11 points). The AUC of the XGBoost model for predicting the death of glioma patients within 5 years after surgery was 0.803 [95% confidence interval (CI): 0.718-0.832], and the sensitivity and specificity were 0.894 and 0.581, respectively. The Youden index was 0.475. The AUC of the multivariate logistic regression model was 0.738 (95% CI: 0.704-0.781), the sensitivity and specificity were 0.785 and 0.632, respectively, and the Youden index was 0.417.

Conclusions: Compared with multivariate logistic regression model, XGBoost model has better performance in predicting the risk of death within 5 years after surgery in patients with glioma.

Keywords: Glioma; XGBoost model; death; multivariate logistic analysis; risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-3384/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Factors associated with death within 5 years after glioma surgery. 1, WHO grade; 2, extent of tumor incision; 3, radiotherapy/chemotherapy; 4, KPS; 5, age; 6, tumor location; 7, smoking; 8, BMI, 9, alcohol consumption. WHO, World Health Organization; KPS, Karnofsy performance score; BMI, body mass index.
Figure 2
Figure 2
The ROC curve of XGBoost model and the logistic model. The AUC of XGBoost is 0.803, and the AUC of the logistic model is 0.738. ROC, receiver operating characteristic; AUC, area under the ROC curve.

Similar articles

Cited by

References

    1. Molinaro AM, Taylor JW, Wiencke JK, et al. Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol 2019;15:405-17. 10.1038/s41582-019-0220-2 - DOI - PMC - PubMed
    1. Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 2014;16:896-913. 10.1093/neuonc/nou087 - DOI - PMC - PubMed
    1. McKinnon C, Nandhabalan M, Murray SA, et al. Glioblastoma: clinical presentation, diagnosis, and management. BMJ 2021;374:n1560. - PubMed
    1. Wu JS, Zhang J, Zhuang DX, et al. Current status of cerebral glioma surgery in China. Chin Med J (Engl) 2011;124:2569-77. - PubMed
    1. Liang S, Fan X, Zhao M, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer Med 2019;8:4527-35. 10.1002/cam4.2362 - DOI - PMC - PubMed